Assembly Biosciences (ASMB) Competitors $24.70 -0.80 (-3.14%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$24.73 +0.03 (+0.12%) As of 08/29/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ASMB vs. NKTR, OMER, CPIX, LLY, JNJ, ABBV, MRK, PFE, BMY, and ZTSShould you be buying Assembly Biosciences stock or one of its competitors? The main competitors of Assembly Biosciences include Nektar Therapeutics (NKTR), Omeros (OMER), Cumberland Pharmaceuticals (CPIX), Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Co., Inc. (MRK), Pfizer (PFE), Bristol Myers Squibb (BMY), and Zoetis (ZTS). These companies are all part of the "pharmaceuticals" industry. Assembly Biosciences vs. Its Competitors Nektar Therapeutics Omeros Cumberland Pharmaceuticals Eli Lilly and Company Johnson & Johnson AbbVie Merck & Co., Inc. Pfizer Bristol Myers Squibb Zoetis Assembly Biosciences (NASDAQ:ASMB) and Nektar Therapeutics (NASDAQ:NKTR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk. Which has more volatility and risk, ASMB or NKTR? Assembly Biosciences has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. Comparatively, Nektar Therapeutics has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Do analysts prefer ASMB or NKTR? Assembly Biosciences currently has a consensus target price of $38.67, indicating a potential upside of 56.55%. Nektar Therapeutics has a consensus target price of $88.33, indicating a potential upside of 195.82%. Given Nektar Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Nektar Therapeutics is more favorable than Assembly Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Assembly Biosciences 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Nektar Therapeutics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Which has stronger valuation & earnings, ASMB or NKTR? Assembly Biosciences has higher earnings, but lower revenue than Nektar Therapeutics. Assembly Biosciences is trading at a lower price-to-earnings ratio than Nektar Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAssembly Biosciences$28.52M6.64-$40.18M-$5.58-4.43Nektar Therapeutics$98.43M5.77-$118.96M-$8.80-3.39 Is ASMB or NKTR more profitable? Assembly Biosciences has a net margin of -117.20% compared to Nektar Therapeutics' net margin of -163.17%. Assembly Biosciences' return on equity of -149.01% beat Nektar Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Assembly Biosciences-117.20% -149.01% -39.04% Nektar Therapeutics -163.17%-631.43%-58.21% Does the media refer more to ASMB or NKTR? In the previous week, Nektar Therapeutics had 4 more articles in the media than Assembly Biosciences. MarketBeat recorded 6 mentions for Nektar Therapeutics and 2 mentions for Assembly Biosciences. Nektar Therapeutics' average media sentiment score of 1.01 beat Assembly Biosciences' score of 0.96 indicating that Nektar Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Assembly Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nektar Therapeutics 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in ASMB or NKTR? 19.9% of Assembly Biosciences shares are owned by institutional investors. Comparatively, 75.9% of Nektar Therapeutics shares are owned by institutional investors. 5.3% of Assembly Biosciences shares are owned by insiders. Comparatively, 5.3% of Nektar Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryNektar Therapeutics beats Assembly Biosciences on 9 of the 16 factors compared between the two stocks. Get Assembly Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ASMB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASMB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASMB vs. The Competition Export to ExcelMetricAssembly BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$189.51M$4.13B$5.75B$9.76BDividend YieldN/A1.28%4.10%4.04%P/E Ratio-4.4311.1983.2726.59Price / Sales6.6413.93535.03111.31Price / CashN/A7.1237.4459.26Price / Book10.474.8610.556.58Net Income-$40.18M-$109.62M$3.27B$265.95M7 Day Performance-8.28%-0.54%0.40%0.17%1 Month Performance37.83%23.54%7.31%3.90%1 Year Performance51.91%29.53%46.58%19.67% Assembly Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASMBAssembly Biosciences3.9107 of 5 stars$24.70-3.1%$38.67+56.5%+51.9%$189.51M$28.52M-4.43100NKTRNektar Therapeutics4.2323 of 5 stars$27.14+0.4%$88.33+225.5%+55.5%$514.07M$98.43M-3.09220News CoveragePositive NewsOMEROmeros4.1683 of 5 stars$4.35-1.1%$18.00+313.8%-1.2%$299.45MN/A-2.06210Positive NewsCPIXCumberland Pharmaceuticals0.5522 of 5 stars$3.26-0.9%N/A+152.9%$49.22M$37.87M-14.8280LLYEli Lilly and Company5 of 5 stars$696.08-2.2%$950.17+36.5%-23.7%$673.57B$45.04B45.5047,000Trending NewsAnalyst UpgradeAnalyst RevisionJNJJohnson & Johnson4.78 of 5 stars$178.53-0.4%$176.29-1.3%+6.8%$431.79B$88.82B19.09138,100Positive NewsEx-DividendABBVAbbVie4.7107 of 5 stars$207.58-1.4%$214.95+3.6%+7.1%$372.04B$56.33B98.8555,000Trending NewsMRKMerck & Co., Inc.4.9955 of 5 stars$85.43-2.2%$107.44+25.8%-28.9%$218.23B$64.17B13.1675,000News CoveragePositive NewsPFEPfizer4.7822 of 5 stars$25.15-2.8%$28.12+11.8%-14.7%$147.14B$63.63B13.3881,000Positive NewsBMYBristol Myers Squibb4.7521 of 5 stars$47.15-1.6%$56.38+19.6%-5.6%$97.54B$48.30B19.0134,100Positive NewsZTSZoetis4.9028 of 5 stars$155.10-1.0%$202.43+30.5%-14.7%$69.41B$9.39B26.7013,800Trending NewsAnalyst Revision Related Companies and Tools Related Companies Nektar Therapeutics Alternatives Omeros Alternatives Cumberland Pharmaceuticals Alternatives Eli Lilly and Company Alternatives Johnson & Johnson Alternatives AbbVie Alternatives Merck & Co., Inc. Alternatives Pfizer Alternatives Bristol Myers Squibb Alternatives Zoetis Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASMB) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assembly Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Assembly Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASMB Stock Alerts